research_news
2024 Myopia Research Highlights: What's New in the Field
Dr. Research Team
February 9, 2026
2 min read
A summary of the most significant myopia research findings and clinical developments from the past year.
Summary
A summary of the most significant myopia research findings and clinical developments from the past year.
2024 Myopia Research Highlights
The field of myopia management continues to advance rapidly. Here are the most significant developments from recent research.
New Treatment Approaches
Red Light Therapy
Emerging research on low-level red light therapy shows promise:
- Some studies report significant efficacy
- Mechanism involves choroidal thickening
- More research needed on long-term safety
- Not yet widely available
Novel Pharmaceutical Agents
Researchers are investigating:
- 7-methylxanthine
- Pirenzepine
- Other muscarinic antagonists
- Dopamine agonists
Combination Therapy Research
New studies confirm benefits of combining treatments:
- Ortho-K + atropine shows additive effects
- Optimal protocols being refined
- Personalized approaches gaining traction
Genetic Research
Progress in understanding myopia genetics:
- Over 500 genetic loci identified
- Polygenic risk scores being developed
- May enable earlier identification of at-risk children
Environmental Factors
Continued research on:
- Optimal outdoor time duration
- Light spectrum effects
- Near work patterns
- Digital device impact
Clinical Guidelines Updates
Professional organizations updating recommendations:
- Earlier intervention emphasized
- Axial length monitoring standard
- Combination therapy acknowledged
- Treatment duration guidance refined
What This Means for Parents
- More treatment options becoming available
- Better understanding of what works
- Personalized treatment approaches improving
- Earlier intervention increasingly recommended